Clinical Trials
3 trialsNCT07581405 2026-05-12
GI-05: The Impact of Olanzapine Among Patients Receiving Neoadjuvant Chemotherapy for Gastric Cancer
University of Illinois at Chicago
Phase 2 Not yet recruiting
NCT05705492 2026-01-21
Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer
OHSU Knight Cancer Institute
Phase 2 Recruiting
NCT03575637 2018-07-03
Olanzapine Improves the Chemotherapy Tolerance of Advanced Gastric Cancer
Peking University
Phase 2 Unknown